ArisGlobal , the leading provider of life sciences software that automates the core functions of drug development with its end-to-end  LifeSphere  LifeSphere technology platform, today announced the acquisition from Amplexor Life Sciences  (LS). Amplexor Life Sciences is a global provider of regulatory, quality and safety software solutions trusted and trusted by pharmaceutical, biotechnology and medical device companies.

The integration of the regulatory product lines will bring many benefits to customers. LifeSphere users now have access to enhanced publishing and labeling capabilities on top of Amplexor LS' robust Quality Management System (QMS). Amplexor LS regulatory customers can now access even broader functionality, including access, through ArisGlobal's market-leading LifeSphere platform on state-of-the-art solutions for security, medical information and clinical solutions.

This combined product ecosystem offers life sciences companies new opportunities by merging the best solutions into a coherent solution that meets customers' regulatory requirements. It also represents many years of industry experience, software innovation and customer focus from ArisGlobal and Amplexor Life Sciences. This move will accelerate both companies' action plans and increase efficiency in bringing new therapies to market.

"For many years, ArisGlobal has been focused on building a regulatory platform that offers a market-leading, comprehensive range of products and streamlines processes that support collaboration across distributed teams while meeting extensive and evolving global regulatory requirements," said Mike Gordon , Chief Executive Officer at ArisGlobal, "By combining our core functions, we are increasing our end-to-end regulatory capabilities to improve customer satisfaction."

"Amplexor Life Sciences has always been committed to providing customers with operational excellence in global compliance, and this new era of products within the LifeSphere Regulatory Platform will continue to do so," said Elvis Pacelat, Executive Vice President at Amplexor LS "We look forward to collaborating with ArisGlobal, a multi-decade innovator in the life sciences field, to bring to the market a full suite of products designed to streamline regulatory processes into a single connected, cloud-based and regulatory framework." corresponding experience".

"The vision and goals of ArisGlobal and Amplexor LS are aligned," said Jim Hilferty , AVP and Head of Regulatory at ArisGlobal. "We are confident that bringing our businesses together will serve as a catalyst for innovation and Life Sciences will enable us to do so , to offer the regulatory community the smartest, connected and most comprehensive platform".

Both companies have supported R&D processes through technology for decades with offices across Europe, the United States, India and the Asia Pacific region.

The integration is subject to customary regulatory approvals, which are expected within the next 60 days. More information about the combined solution will be made available.

Visit  arisglobal.com  and  amplexorlifesciences.com for more information .

 

Source:prnewswire.com

Report Abuse